Biomarin Pharmaceutical Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Novato, CA
BMRN chart
What traders are saying about $BMRN
Latest postsBiomarin Pharmaceutical Inc news
- BioMarin Pharmaceutical (BMRN) Could Be 24% Undervalued Ahead Of Its November 2 Results Call
Simply Wall Street ·
- BioMarin Pharmaceutical Inc. (BMRN) stock price, news, quote and history
Yahoo Finance Singapore ·
- BioMarin Pharmaceutical (BMRN): Amicus Acquisition Accelerates Revenue Growth
AlphaStreet ·
- BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4:30pm ET
Yahoo Finance ·
- A third-quarter results call will include a business update from BioMarin’s CEO on Nov. 2.
Stock Titan ·
- Vertex Stock Looks Expensive. Does It Get Cheaper Ahead?
trefis.com ·
- Earnings Preview: Bristol Myers Squibb (BMY) Q3 Earnings Expected to Decline
Yahoo Finance ·
- BioMarin Pharmaceutical (NasdaqGS:BMRN) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts
Yahoo Finance ·
- BioMarin Pharmaceutical Lobbying Profile, 2025
OpenSecrets ·
- Why Should You Think About Vertex Differently Now?
trefis.com ·
- BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?
Yahoo Finance ·
Biomarin Pharmaceutical Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.22B | $2.85B | $2.42B | $2.10B |
| Net income | $348.9M | $426.9M | $167.6M | $141.6M |
| Diluted EPS | $1.80 | $2.21 | $0.87 | $0.75 |
| Total assets (year end) | $7.59B | $6.99B | $6.84B | $6.38B |
| Cash and equivalents (year end) | $1.31B | $942.8M | $755.1M | $724.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Biomarin Pharmaceutical Inc
- Ticker
- BMRN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Novato, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1048477
Frequently asked questions
What exchange is Biomarin Pharmaceutical Inc listed on?
Biomarin Pharmaceutical Inc trades on the Nasdaq under the ticker symbol BMRN.
What industry is Biomarin Pharmaceutical Inc in?
Biomarin Pharmaceutical Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Biomarin Pharmaceutical Inc headquartered?
Biomarin Pharmaceutical Inc's business address on file with the SEC is in Novato, CA.
When does Biomarin Pharmaceutical Inc's fiscal year end?
Biomarin Pharmaceutical Inc's fiscal year ends on December 31.
How much revenue did Biomarin Pharmaceutical Inc report?
Biomarin Pharmaceutical Inc reported $3.22B in revenue for calendar year 2025, according to its SEC filings.